Evidence map›Paper›PMID 36215295›Full record

ArticlePloS one2022

In vitro osteoblast activity is decreased by residues of chemicals used in the cleaning and viral inactivation process of bone allografts.

Guillaume Villatte, Roger Erivan, Stéphane Descamps, Pierre Arque, Stéphane Boisgard, Yohann Wittrant

Expression of concernOpen access · goldAbstract read
In one paragraph

Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It carries an expression of concern. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 53% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Guillaume VillatteClermont Auvergne University, CNRS, SIGMA Clermont, ICCF, Clermont-Ferrand, France.ORCID 0000-0002-4322-6304
Roger ErivanClermont Auvergne University, CNRS, SIGMA Clermont, ICCF, Clermont-Ferrand, France.
Stéphane DescampsClermont Auvergne University, CNRS, SIGMA Clermont, ICCF, Clermont-Ferrand, France.
Pierre ArqueClermont Auvergne University, CNRS, SIGMA Clermont, ICCF, Clermont-Ferrand, France.
Stéphane BoisgardClermont Auvergne University, CNRS, SIGMA Clermont, ICCF, Clermont-Ferrand, France.
Yohann WittrantINRAE, Clermont Auvergne University, UMR 1019 Human Nutrition, Clermont-Ferrand, France.
Centre National de la Recherche Scientifique · FRUnité de Nutrition Humaine · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Allograft bone tissue has a long history of use. There are two main ways of preserving allografts: by cold (freezing), or at room temperature after an additional cleaning treatment using chemicals. These chemicals are considered potentially harmful to humans. The aim of the study was (i) to assess the presence of chemical residues on processed bone allografts and (ii) to compare the in vitro biocompatibility of such allografts with that of frozen allografts. The presence of chemical residues on industrially chemically treated bone was assessed by high performance liquid chromatography (HPLC) after extraction. Biocompatibility analysis was performed on primary osteoblast cultures from Wistar rats grown on bone disks, either frozen (F-bone group) or treated with supercritical carbon dioxide with no added chemical (scCO2-bone group) or industrially treated with chemicals (CT-bone group). Cell viability (XTT) was measured after one week of culture. Osteoblastic differentiation was assessed after 1, 7 and 14 days of culture by measuring alkaline phosphatase (ALP) activity directly on the bone discs and indirectly on the cell mat in the vicinity of the bone discs. Residues of all the chemicals used were found in the CT-bone group. There was no significant difference in cell viability between the three bone groups. Direct and indirect ALP activities were significantly lower (-40% to -80%) in the CT-bone group after 7 and 14 days of culture (p < 0.05). Residues of chemical substances used in the cleaning of bone allografts cause an in vitro decrease in their biocompatibility. Tissue cleaning processes must be developed that limit or replace these chemicals to favor biocompatibility.

Indexed as

Bone TransplantationOsteoblastsVirus InactivationAlkaline PhosphataseAllograftsAnimalsCarbon DioxideRatsRats, WistarAlkaline PhosphataseCarbon Dioxide

Identifiers

PMID36215295
PMCPMC9550034
OpenAlexW4304087158

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.